Try the modernized beta website. Learn more about the modernization effort.

Key Record Dates Identifier: NCT03631784
Brief Title: A Trial of Pembrolizumab in Combination With Chemotherapy and Radiotherapy in Stage III NSCLC (KEYNOTE-799, MK-3475-799). (KEYNOTE-799)

First Submitted : August 13, 2018
First Submitted that Met QC Criteria : August 13, 2018
First Posted : August 15, 2018

Last Update Submitted that Met QC Criteria : November 1, 2021
Last Update Posted : November 9, 2021